[1]胡 涛,耿排力.中药制剂及外源性细胞因子对化疗损伤小鼠 细胞因子及NK细胞活性的影响[J].中国中医药信息杂志,2004,11(1):33-35.
 HU Tao,GENG Pai-li.Regulatory Mechanism of Traditional Chinese Medicine and Cytokines on the Injury of Chemotherapeutical Mouse[J].zhongguo zhongyiyao xinxi zazhi,2004,11(1):33-35.
点击复制

中药制剂及外源性细胞因子对化疗损伤小鼠 细胞因子及NK细胞活性的影响

参考文献/References:

[1] 王海燕,孙丰润,胡 涛,等.人参养荣片对化疗损伤小鼠免疫功能的调节[J].滨州医学院学报,1997,20(6):523.
[2] 杨贵贞.免疫生物工程纲要与技术[M].长春:吉林科学出版社,1991. 17.
[3] 金伯泉.细胞和分子免疫学[M].第2版.北京:科学出版社,2001.136.
[4] Gately MG, Renzetti LM, Magram J, et al. The interlukin-12/interleukin-12 receptor system:role in normal and pathologic immine responses[J]. Ann Rev Immunol,1998,16:495.
[5] Gately MK, Guble U, Brunda MJ, et al. Interleukin-12 a cytokine with therapeutic potential in oncology and infection disease[J]. Therapeutic Immunol,1994,1:187.
[6] Chehimi J, Valiante NM, D'Andrea A, et al. Enhancing effect of natural killer cell stimulatory factor (CNKSF/IL-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells[J]. Eur J Immunol,1993,23:1826.
[7] 李光勋.中药药理毒理与临床[M].天津:天津科技翻译出版公司, 1992.158.
[8] Romani N, Gruner S, Brang D, et al. Proliferration dendritic cell progenitors in human blood[J]. J Exp Med,1994,180(1):83.
[9] Hart DN. Dendritic cells:unique leukcyte population which control the primary immune response[J].Blood,1997,90(9):3245.
[10] Romain N,Reider D,Heuer M,et al.Generation of mature dendritic cell from human blood. An improves method with special regard to clinical applicability[J]. J Immunol Method,1996,196 (2):137.

相似文献/References:

[1]李林,李先荣,倪艳.糖复平胶囊薄层色谱鉴别研究[J].中国中医药信息杂志,2009,16(2):51.
 LI Lin,LI Xian-rong,NI Yan.Study on TLC Identification for Tangfuping Capsule[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):51.
[2]丁乡.东北人参2007-2008年度走势浅析[J].中国中医药信息杂志,2008,15(7):112.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(1):112.
[3]周倩倩,黄力.人参药物后适应在心肌缺血再灌注损伤中的保护作用[J].中国中医药信息杂志,2011,18(5):107.[doi:10.3969/j.issn.1005-5304.2011.05.053]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):107.[doi:10.3969/j.issn.1005-5304.2011.05.053]
[4]柴程芝,刘志刚,黄煌.从人参药证的历史演变谈中药功效合理评价的意义[J].中国中医药信息杂志,2012,19(8):8.[doi:10.3969/j.issn.1005-5304.2012.08.004]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(1):8.[doi:10.3969/j.issn.1005-5304.2012.08.004]
[5]汪洋.《血证论》人参生津启源功效探析[J].中国中医药信息杂志,2014,21(5):107.[doi:10.3969/j.issn.1005-5304.2014.05.036]
 [J].zhongguo zhongyiyao xinxi zazhi,2014,21(1):107.[doi:10.3969/j.issn.1005-5304.2014.05.036]
[6]曲淑兰.人参、五灵脂合用治疗胸痹体会[J].中国中医药信息杂志,2006,13(11):85.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(1):85.
[7]叶祖光,薛宝云,戴宝强,等.三七总皂甙和人参总皂甙药理作用的比较研究[J].中国中医药信息杂志,1996,3(5):11.
[8]李月华,华海婴,叶启霞,等.气血葆口服液对放化疗毒性作用的影响[J].中国中医药信息杂志,1996,3(7):13.
[9]黄晓会,沈艳琳,陈俊珺,等.人参中41种有机磷农药多残留分析方法[J].中国中医药信息杂志,2015,22(3):86.[doi:10.3969/j.issn.1005-5304.2015.03.023]
 HUANG Xiao-hui,SHEN Yan-lin,CHEN Jun-jun,et al.Analytical Method for Determination of 41 Organophosphorus Pesticide Retention in Ginseng[J].zhongguo zhongyiyao xinxi zazhi,2015,22(1):86.[doi:10.3969/j.issn.1005-5304.2015.03.023]
[10]鹿扩建,曹欢,笔雪艳,等.基于人参炮制历史沿革探讨中国药典中红参炮制规范[J].中国中医药信息杂志,2020,27(8):27.[doi:10.3969/j.issn.1005-5304.201904432]
 LU Kuojian,CAO Huan,BI Xueyan,et al.Study on Processing Standard of Red Ginseng in Chinese Pharmacopoeia Based on Historical Evalution of Ginsengs Processing[J].zhongguo zhongyiyao xinxi zazhi,2020,27(1):27.[doi:10.3969/j.issn.1005-5304.201904432]

更新日期/Last Update:

1900-01-01